The anti-S1 IgG antibody concentration of hybrid immunity (previous infection and two doses of mRNA vaccine) in patients with B-lymphocyte lymphoid malignancies was higher than in the patients who had not had a previous infection. This evidence concerns the gene PSMD1 and infection.